Human papilloma virus DNA exposure and embryo survival is stage-specific

Journal of Assisted Reproduction and Genetics

Volumn 23, Issue 6, 2006, Pages 255-259

  Henneberg, Andrew A ^a   Patton, William C ^a   Jacobson, John D ^a   Chan, Philip J ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Embryogenesis; HPV; Human papillomavirus; Preimplantation embryo

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLASTOCYST; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL;

ANIMALS; BLASTOCYST; DNA, VIRAL; EMBRYONIC DEVELOPMENT; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; MICE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33748776540     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-006-9030-8     Document Type: Article

References (40)

1. Graham DA, Herrington CS: The induction of chromosome abnormalities by human papillomaviruses. Papillomavirus 1998;9:1-5
2. Revzina NV, Diclemente RJ: Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. Int J STD AIDS 2005;16:528-537
3. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992;52:5323-5328
4. Hermonat PL, Kechelava S, Lowery CL, Korourian S: Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception. Hum Pathol 1998;29:170-174
5. Hermonat PL, Han L, Wendel PJ, Quirk JG, Stern S, Lowery CL, Rechtin TM: Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Gen 1997;14:13-17
6. Manavi M, Czerwenka KF, Schurz B, Knogler W, Kubista E, Reinold E: Latent cervical virus infection as a possible cause of early abortion. Gynakol Geburtshilfliche Rundsch 1992;32:84-87
7. Malhomme O, Dutheil N, Rabreau M, Armbruster-Moraes E, Schlehofer JR, Dupressoir T: Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses, adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA. J Gen Virol 1997;78:1957-1962
8. Sifakis S, Ergazaki M, Sourvinos G, Koffa M, Koumantakis E, Spandidos DA: Evaluation of parvo B19, CMV, and HPV viruses in human aborted material using polymerase chain reaction technique. Eur J Obstet Gynecol Reprod Biol 1998;76:169-173
9. Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, Alford CA. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med 1982;306:945-949
10. Icart J, Didier J, Dalens M, Chabanon G, Boucays A: Prospective study of EBV infection during pregnancy. Biomedicine 1981;34:160-163
11. Brown ZA, Vontver LA, Benedetti J, Critchlow CW, Sells CJ, Berry S, Corey L: Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246-1251
12. Monif GR: Maternal mumps infections during gestation: Observations in the progeny. Am J Obstet Gynecol 1974;119:549-551
13. Miller E, Cradock-Watson JE, Pollock TM: Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781-784
14. Alani RM, Münger K: Human papillomaviruses and associated malignancies. J Clin Oncol 1997;16:330-337
15. Saiki RK, Walsh PS, Levenson CH, Erlich HA: Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 1989;86:6230-6234
16. Erlich HA, Bugawan TL: HLA class II gene polymorphism: DNA typing, evolution, and relationship to disease susceptibility. In PCR Technology: Principles and Applications for DNA Amplifications, Erlich HA (ed.), New York, Stockton Press, 1989; pp. 193-208,
17. Ting Y, Manos MM: Detection and typing of genital human papillomaviruses. In PCR Protocols, Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds.), New York, Academic Press, 1990; pp. 356-367
18. Sarkar FH, Crissman JD: Detection of human papilloma virus DNA sequences by polymerase chain reaction. Biotechniques 1990;9:180-185
19. Chan PJ, Kalugdan TH, Cabrera M, Seraj IM, King A: Detection of exogenous DNA in blastocysts after continuous exposure to DNA carrier sperm. J Assist Reprod Genetics 1996;13:602-605
20. Rowland SC, Jacobson JD, Patton WC, King A, Chan PJ: Dual fluorescence analysis of DNA apoptosis in sperm. Am J Obstet Gynecol 2003;188:1156-1157
21. Calinisan JH, Chan SR, King A, Chan PJ: Human papillomavirus and blastocyst apoptosis. J Assist Reprod Genet 2002;19:132-136
22. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505
23. Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ, Scheffner M: Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci USA 2001;98:1218-1223
24. Graham DA, Herrington CS: The induction of chromosome abnormalities by human papillomaviruses. Papillomavirus Rep 1998;9:1-5
25. Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-937
26. Massimi P, Pim D, Banks L: Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box protein and this contributes to E& transforming activity. J Gen Virol 1997;78:2607-2613
27. Dürst M, Croce CM, Gissmann L, Schwarz E, Huebner K: Papillomavirus sequences integrate nearcellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987;84:1070-1074
28. Yunis JJ, Soreng AL, Bowe AE: Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1987;1:59-69
29. Cannizzaro LA, Dürst M, Mendez MJ, Hecht BK, Hecht F: Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes and cancer chromosome breakpoints. Cancer Genet Cytogenet 1988;33:93-98
30. Popescu NC, DiPaolo JA: Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet 1989;42:157-71
31. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R-III, Le Beau MM: Preferential integration of marker DNA into the chromosomal fragile site at 3p14: An approach to cloning fragile sites. Proc Natl Acad Sci USA 1991;88:6657-6661
32. Smith PP, Friedman CL, Bryant EM, McDougall JK: Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes, Chromosom Cancer 1995;5:150-157
33. Kessis TD, Connolly DC, Hedrick L, Cho KR: Expression of HPV 16 E6 or E7 increases integration of foreign DNA. Oncogene 1996;13:427-431
34. Ferber MJ, Eilers P, Schuuring E, Fenton JAL, Fleuren GJ, Kenter G, Szuhai K, Smith DI, Raap AK, Brink AATP: Positioning of cervical carcinoma and Burkitt lymphoma translocationn breakpoints with respec to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet 2004;154:1-9
35. Gallego MI, Lazo PA: Deletion in human chromosome region 12q13-15 by integration of human papillomvirus DNA in a cervical carcinoma cell line. J Biol Chem 1995;270:24321-24326
36. Tanaka H, Karube A, Kodama H, Fukuda J, Tanaka T: Mass screening for human papillomavirus type 16 infection in infertile couples. J Reprod Med 2000;45:907-911
37. Strehler E, Sterzik K, Malthaner D, Hoyer H, Nindl I, Schneider A: Influence of ovarian stimulation on the detection of human papillomavirus DNA in cervical scrapes obtained from patients undergoing assisted reproductive techniques. Fertil Steril 1999;71:815-820
38. Repper CF, Carranza-Lira S, Alcivia GJC, Gaona AR, Garcia LA: Modified factors in the study of the infertile couple in women with papillomavirus cervical infection, descriptive analysis. Ginecol Obstet Mex 1995;63:502-504
39. Schiff M, Miller J, Masuk M, van Asselt King L, Altobelli KK, Wheeler CM, Becker TM: Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women. Int J Epidemiol. 2000;29:983-990
40. Lundqvist M, Westin C, Lundkvist O, Simberg N, Strand A, Andersson S, Wilander E: Cytologic screening and human papilloma virus test in women undergoing artificial fertilization. Acta Obstet Gynecol Scand 2002;81:949-953